Cite
HARVARD Citation
Bernstein, D. et al. (2020). Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. Lancet infectious diseases. 20 (1), pp. 80-91. [Online].